Validation of a CD1b tetramer assay for studies of human mycobacterial infection or vaccination

• Published in: Journal of immunological methods 2018-07, Vol.458, p.44-52
• Main Authors: Layton, Erik D., Yu, Krystle K.Q., Smith, Malisa T., Scriba, Thomas J., De Rosa, Stephen C., Seshadri, Chetan
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Antigens, Bacterial - immunology; Antigens, CD1 - immunology; Antigens, CD1 - metabolism; Assay validation; CD1b; Cell Culture Techniques; Cell Line; Cross-Sectional Studies; Epitopes, T-Lymphocyte - immunology; Flow Cytometry - instrumentation; Flow Cytometry - methods; Glycolipids - chemistry; Glycolipids - immunology; Healthy Volunteers; Human; Humans; Immunogenicity, Vaccine; Latent Tuberculosis - diagnosis; Latent Tuberculosis - immunology; Latent Tuberculosis - microbiology; Latent Tuberculosis - prevention & control; Mycobacteria; Mycobacterium tuberculosis - immunology; Mycobacterium tuberculosis - isolation & purification; Protein Multimerization - immunology; South Africa; T cells; T-Lymphocytes - immunology; T-Lymphocytes - metabolism; Tetramer; Tuberculosis Vaccines - administration & dosage; Tuberculosis Vaccines - immunology; United States
• ISSN: 0022-1759; 1872-7905
• DOI: 10.1016/j.jim.2018.04.004

CD1 tetramers loaded with lipid antigens facilitate the identification of rare lipid-antigen specific T cells present in human blood and tissue. Because CD1 proteins are structurally non-polymorphic, these tetramers can be applied to genetically diverse human populations, unlike MHC-I and MHC-II tetramers. However, there are no standardized assays to quantify and characterize lipid antigen-specific T cells present within clinical samples. We incorporated CD1b tetramers loaded with the mycobacterial lipid glucose monomycolate (GMM) into a multi-parameter flow cytometry assay. Using a GMM-specific T-cell line, we demonstrate that the assay is linear, reproducible, repeatable, precise, accurate, and has a limit of detection of approximately 0.007%. Having formally validated this assay, we performed a cross-sectional study of healthy U.S. controls and South African adolescents with and without latent tuberculosis infection (LTBI). We show that GMM-specific T cells are specifically detected in South African subjects with LTBI and not in U.S. healthy controls. This assay can be expanded to include additional tetramers or phenotypic markers to characterize GMM-specific T cells in studies of mycobacterial infection, disease, or vaccination.